UC Berkeley Loses CRISPR Gene-Editing Patent Case
March 4, 2022
55 min
Full
1,176 of 3,393
March 4, 2022
UC Berkeley Loses CRISPR Gene-Editing Patent Case
0:00 / 55:47
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
America the Jesuit Review Episodes Around March 4, 2022
Episode 1,176 of 3,393 — walk the feed in the order it was published.
New Book Chronicles the 'Sickening' Influence of Big Pharma on Healthcare
UC Berkeley Loses CRISPR Gene-Editing Patent Case
Summary
In 2020, UC Berkeley scientist Jennifer Doudna, along with French scientist Emanuelle Charpentier, won a Nobel prize for her work on the revolutionary method for editing DNA known as CRISPR. But this week Doudna's lab at UC Berkeley lost its case with the U.S. patent office, stripping it of key patent rights to the tool and anywhere from 100 million to 10 billion dollars in potential licensing revenue, according to experts. We’ll talk about what the ruling means for UC Berkeley and the possible ripple effects within the biotech industry.
Guests:
Megan Molteni , Science writer, STAT News
Samantha Zyontz, Research fellow, Intellectual Property and Fellow, Center for Law and Biosciences, Stanford University
Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.